GlassScriptPhysician profile
Rustan J Van Wyk
NPI 1861474439
$2,561.55
in general payments reported to CMS, 2019-2025
26 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.32 · 2020: $231 · 2021: $513 · 2022: $435 · 2023: $372 · 2024: $657 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Travel and Lodging: $107 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.51 |
| Travel and Lodging | $107.00 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $457.28 | 2020-2024 | |
| Procept Biorobotics Corporation | $295.15 | 2024 | Aquabeam System |
| Endo Pharmaceuticals INC. | $275.88 | 2021-2023 | Xiaflex, Aveed |
| Abbvie INC. | $243.89 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.84 | 2023-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $138.29 | 2025 | |
| Merck Sharp & Dohme LLC | $124.80 | 2021-2023 | Verquvo, Lynparza, Keytruda |
| Olympus America INC. | $111.23 | 2019-2025 | Itind System, Uretero-Reno Videoscope |
| Baxter Healthcare | $91.91 | 2020 | |
| Endo USA, INC. | $91.55 | 2024 | Xiaflex |
| Pfizer INC. | $87.43 | 2020-2021 | |
| Urogen Pharma, INC. | $64.34 | 2023-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $63.24 | 2022-2025 | Provenge |
| Janssen Biotech, INC. | $52.19 | 2025 | Erleada |
| Accord Healthcare, INC. | $44.43 | 2023-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $44.38 | 2024 | Watchman Flx |
| Urovant Sciences INC | $44.28 | 2022 | |
| Neotract INC. | $44.22 | 2019 | |
| Laborie Medical Technologies Corp. | $27.99 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $24.37 | 2025 | Gemtesa |
| Axonics, INC. | $22.31 | 2023 | Axonics |
| Baudax Bio INC. | $14.97 | 2020 | |
| Hollister Incorporated | $13.61 | 2024 | |
| Abc Home Medical Supply, INC. | $13.61 | 2024 | |
| Medtronic USA, INC. | $13.23 | 2020 | |
| Rgh Enterprises LLC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rustan Van Wyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.